| 1 | H-116PI-DE.pdf | - | - | - | - | 1件: 18 18 |
| 2 | H-ATG (ATGAM ) | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
| 3 | H.P. Acthar Gel | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 46 46, 49, 50, 84, 222 |
| 4 | H.P. Acthar Gel (repository corticotropin injection) | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 |
| 5 | H.P. Acthar® Gel | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 14 14 |
| 6 | H01AC01 | - | - | - | - | 1件: 78 78 |
| 7 | H01BB02 | - | - | - | - | 1件: 193 193 |
| 8 | H02 - Corticosteroidi Sistemici | - | - | - | - | 1件: 299 299 |
| 9 | H02AB | - | - | - | - | 1件: 97 97 |
| 10 | H02AB02 | - | - | - | - | 1件: 28 28 |
| 11 | H02AB02 Desametasone | - | - | - | - | 1件: 28 28 |
| 12 | H02AB04 | - | - | - | - | 1件: 46 46 |
| 13 | H02AB07 | - | - | - | - | 1件: 46 46 |
| 14 | H02AB09 | - | - | - | - | 1件: 41 41 |
| 15 | H05AA02 | - | - | - | - | 1件: 274 274 |
| 16 | H1 Blocker | - | - | - | - | 1件: 257 257 |
| 17 | H2 Blocker | - | - | - | - | 1件: 257 257 |
| 18 | H44AON188 | - | - | - | - | 1件: 113 113 |
| 19 | H5.001CBCFTR | - | - | - | - | 1件: 299 299 |
| 20 | H51AON23 | - | - | - | - | 1件: 113 113 |
| 21 | H5G1.1-mAb | - | - | - | - | 3件: 13 13, 50, 62 |
| 22 | HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM | - | - | - | - | 2件: 6 6, 49 |
| 23 | HA20 (IMMU-106) | - | - | - | - | 1件: 46 46 |
| 24 | Habitrol | - | - | - | - | 1件: 84 84 |
| 25 | Haemate P | - | - | - | - | 1件: 288 288 |
| 26 | Haemate P® (Human Coagulation Factor VIII) | 1件: Antihemophilic factor human Antihemophilic factor human | - | - | - | 1件: 288 288 |
| 27 | Haemate-P, Wilate | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 28 | Haemate® P 250 | - | - | - | - | 1件: 288 288 |
| 29 | Haemoblock | - | - | - | - | 2件: 157 157, 280 |
| 30 | Haemocomplettan P | - | - | - | - | 1件: 65 65 |
| 31 | Haemocomplettan(R) P | - | - | - | - | 1件: 65 65 |
| 32 | Haemocomplettan(R) P 1g/2g | - | - | - | - | 1件: 65 65 |
| 33 | HAEMOPHILUS INFLUENZAE | - | - | - | - | 3件: 61 61, 62, 66 |
| 34 | HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - | - | 2件: 13 13, 14 |
| 35 | Haemophilus type b vaccine (conjugated) | - | - | - | - | 1件: 14 14 |
| 36 | Haemostasis tests | - | - | - | - | 1件: 113 113 |
| 37 | HAESCs | - | - | - | - | 1件: 6 6 |
| 38 | HAESCs treatment | - | - | - | - | 1件: 6 6 |
| 39 | Halometasone | 1件: Halometasone Halometasone | 1件: D07202
D07202
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 |
| 40 | Haloperidol | 1件: Haloperidol Haloperidol | 1件: D00136
D00136
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 8 8 |
| 41 | Haloperidol 2Mg Tab | 1件: Haloperidol Haloperidol | 1件: D00136
D00136
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 8 8 |
| 42 | Haplo BM with T cell depletion | - | - | - | - | 1件: 65 65 |
| 43 | Haplo/cord transplant | - | - | - | - | 1件: 60 60 |
| 44 | Haploidentical Hematopoietic Cell Transplantation | - | - | - | - | 2件: 60 60, 65 |
| 45 | Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide'' | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 1件: 60 60 |
| 46 | Harmonized supportive care | - | - | - | - | 2件: 38 38, 39 |
| 47 | HATG | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
| 48 | Havrix | - | - | - | - | 1件: 46 46 |
| 49 | HB-adMSCs | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 5件: 2 2, 6, 13, 14, 46 |
| 50 | HB0034 | - | - | - | - | 1件: 37 37 |
| 51 | HBM9161 Dose A | - | - | - | - | 1件: 63 63 |
| 52 | HBM9161 Dose B | - | - | - | - | 1件: 63 63 |
| 53 | HBM9161 Injection | - | - | - | - | 1件: 13 13 |
| 54 | HBM9161 Injection (340 mg) | - | - | - | - | 1件: 11 11 |
| 55 | HBM9161 Injection (680mg and 340 mg) | - | - | - | - | 1件: 11 11 |
| 56 | HBM9161 Injection (680mg) | - | - | - | - | 1件: 11 11 |
| 57 | HBVAXPRO | - | - | - | - | 2件: 46 46, 50 |
| 58 | HBVAXPRO 5 micrograms/0.5 ml | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
| 59 | HBVAXPRO 5 micrograms/0.5 ml Suspension for injection Hepatitis B vaccine (rDNA) | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
| 60 | HBVAXPRO® 40 micrograms | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
| 61 | HC-58 | - | - | - | - | 1件: 149 149 |
| 62 | HCQ | - | - | - | - | 2件: 46 46, 49 |
| 63 | HCQ/CQ and CAB combined treatment | - | - | - | - | 1件: 74 74 |
| 64 | HCT | - | - | - | - | 1件: 67 67 |
| 65 | HD-TIV | - | - | - | - | 1件: 46 46 |
| 66 | HE3286 | 1件: HE3286 HE3286 | - | - | - | 2件: 46 46, 97 |
| 67 | Healthy | - | - | - | - | 1件: 6 6 |
| 68 | HEC 68498 | - | - | - | - | 1件: 85 85 |
| 69 | HEC122505MsOH | - | - | - | - | 1件: 6 6 |
| 70 | HEC585 | - | - | - | - | 1件: 85 85 |
| 71 | Helicobacter pylori eradication therapy | - | - | - | - | 1件: 6 6 |
| 72 | Helium | 1件: Helium Helium | 1件: D04420
D04420
| - | - | 3件: 228 228, 299, 330 |
| 73 | Helium / oxygen mixed gas inhalation therapy | 2件: Helium Helium,
Oxygen | 2件: D00003
D00003
,
D04420
| - | - | 1件: 330 330 |
| 74 | Helium-3 | 2件: Helium Helium,
Helium He-3 | 1件: D04420
D04420
| - | - | 2件: 228 228, 299 |
| 75 | Helminth ova | - | - | - | - | 1件: 13 13 |
| 76 | Helopanflat Mono® | - | - | - | - | 1件: 298 298 |
| 77 | Hematide | 1件: Peginesatide Peginesatide | 1件: D09946
D09946
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 |
| 78 | Hematide, peginesatide | 1件: Peginesatide Peginesatide | 1件: D09946
D09946
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 |
| 79 | Hematopoetic Stem Cell Transplantation | - | - | - | - | 5件: 19 19, 65, 120, 160, 326 |
| 80 | Hematopoietic stem cell infusion | - | - | - | - | 2件: 19 19, 20 |
| 81 | Hematopoietic Stem Cell Transplant | - | - | - | - | 1件: 65 65 |
| 82 | Hematopoietic Stem Cell Transplantation | - | - | - | - | 12件: 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 |
| 83 | Hemay005 | - | - | - | - | 2件: 56 56, 271 |
| 84 | Hemay007 | - | - | - | - | 1件: 97 97 |
| 85 | Hemay007 1200 mg QD group | - | - | - | - | 1件: 46 46 |
| 86 | Hemay007 600 mg QD group | - | - | - | - | 1件: 46 46 |
| 87 | Hemay007 800 mg QD group | - | - | - | - | 1件: 46 46 |
| 88 | Heme arginate | 1件: Heme arginate Heme arginate | - | - | - | 1件: 254 254 |
| 89 | Hemin | 1件: Hemin Hemin | 1件: D10003
D10003
| 2件: ALAS1 ALAS1,
ALAS2 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬 | 1件: 254 254 |
| 90 | Hemin for injection | 1件: Hemin Hemin | 1件: D10003
D10003
| 2件: ALAS1 ALAS1,
ALAS2 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬 | 1件: 254 254 |
| 91 | Hemlibra | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10,
F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
| 92 | Hemlibra® | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10,
F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
| 93 | HEMOFIX | - | - | - | - | 1件: 288 288 |
| 94 | Heparesc | - | - | - | - | 1件: 251 251 |
| 95 | Heparin | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 11件: 47 47, 60, 70, 84, 107, 224, 226, 280, 299, 316, 317 |
| 96 | Heparin & Alkalinized Lidocaine Bladder Instillation | 2件: Heparin Heparin,
Lidocaine | 3件: D00358
D00358
,
D07510
,
D08127
| 6件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬 | 4件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬 | 1件: 226 226 |
| 97 | Heparin 25mg inhalation powder, hard capsule | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 299 299 |
| 98 | Heparin Sodium | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 280 280, 299 |
| 99 | Heparán N sulfatasa humana recombinante | - | - | - | - | 1件: 19 19 |
| 100 | Heparán N sulfatasa humana recombinante (rhHNS) | - | - | - | - | 1件: 19 19 |
| 101 | HepaStem | - | - | - | - | 1件: 251 251 |
| 102 | HepaStem Infusion | - | - | - | - | 1件: 251 251 |
| 103 | Hepatitis A Vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 3件: 46 46, 96, 97 |
| 104 | Hepatitis A vaccine ( HAVRIX or EPAXAL) | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 1件: 46 46 |
| 105 | Hepatitis A vaccine and tetanus vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 1件: 46 46 |
| 106 | Hepatitis B Vaccine | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
| 107 | HEPATITIS B VACCINE (RDNA) | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
| 108 | HEPATITIS B VIRUS SURFACE ANTIGEN RECOMBINANT (S PROTEIN) | - | - | - | - | 1件: 46 46 |
| 109 | Heptaminol | 1件: Heptaminol Heptaminol | 1件: D07158
D07158
| - | - | 1件: 6 6 |
| 110 | Heptaminol hydrochloride | 1件: Heptaminol Heptaminol | 1件: D07158
D07158
| - | - | 1件: 6 6 |
| 111 | Heracillin | - | - | - | - | 1件: 299 299 |
| 112 | Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.) | 1件: Reynoutria multiflora root Reynoutria multiflora root | - | - | - | 1件: 6 6 |
| 113 | Herbal medicine | - | - | - | - | 1件: 70 70 |
| 114 | Herbal treatment (SA100) | - | - | - | - | 1件: 97 97 |
| 115 | Hericium erinaceus mycelium | - | - | - | - | 1件: 6 6 |
| 116 | Herombopag | - | - | - | - | 2件: 60 60, 63 |
| 117 | Herpes Zoster Subunit (HZ/su) Vaccine | - | - | - | - | 1件: 49 49 |
| 118 | Herpes Zoster Vaccine | - | - | - | - | 3件: 46 46, 96, 271 |
| 119 | HESC-RPE | - | - | - | - | 1件: 301 301 |
| 120 | Heshouwu | 1件: Reynoutria multiflora root Reynoutria multiflora root | - | - | - | 1件: 6 6 |
| 121 | Hesperidin | 1件: Hesperidin Hesperidin | 1件: D01038
D01038
| - | - | 2件: 46 46, 93 |
| 122 | Heterologous booster | - | - | - | - | 1件: 13 13 |
| 123 | Heterologous Human Adult Liver-derived Progenitor Cells | - | - | - | - | 1件: 251 251 |
| 124 | Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC) | - | - | - | - | 1件: 251 251 |
| 125 | Hetrombopag | 1件: Hetrombopag Hetrombopag | - | - | - | 2件: 60 60, 63 |
| 126 | Hetrombopag Olamine | 1件: Hetrombopag Hetrombopag | - | - | - | 2件: 60 60, 63 |
| 127 | Hetrombopag Olamine Tablet | 1件: Hetrombopag Hetrombopag | - | - | - | 1件: 60 60 |
| 128 | Hextend | 1件: Hydroxyethyl Starch Hydroxyethyl Starch | 1件: D03335
D03335
| - | - | 2件: 96 96, 97 |
| 129 | HF0220 | - | - | - | - | 1件: 6 6 |
| 130 | HF2 | - | - | - | - | 1件: 97 97 |
| 131 | Hgd40 | - | - | - | - | 1件: 97 97 |
| 132 | HGH | - | - | - | - | 1件: 78 78 |
| 133 | HGH-hyFc, recombinant human growth hormone | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 |
| 134 | HGH-ViaDerm™ System (hGH or somatropin) | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 |
| 135 | HGP1206 | - | - | - | - | 1件: 86 86 |
| 136 | HGS1006 | - | - | - | - | 1件: 49 49 |
| 137 | HGS1006, LymphoStat-B | - | - | - | - | 1件: 53 53 |
| 138 | HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA | 1件: Belimumab Belimumab | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 49 49, 53 |
| 139 | HGS1025 | - | - | - | - | 1件: 97 97 |
| 140 | HGT-1110 | - | - | - | - | 1件: 19 19 |
| 141 | HGT-1111 | - | - | - | - | 1件: 19 19 |
| 142 | HGT-1410 | - | - | - | - | 1件: 19 19 |
| 143 | HGT-2310 | - | - | - | - | 1件: 19 19 |
| 144 | HHALPC | - | - | - | - | 1件: 251 251 |
| 145 | HHLivC | - | - | - | - | 1件: 251 251 |
| 146 | Hiberix | 1件: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 4件: 13 13, 61, 62, 66 |
| 147 | HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML | 1件: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 3件: 61 61, 62, 66 |
| 148 | HIDONAC*EV 1FL 5G 25ML | - | - | - | - | 1件: 51 51 |
| 149 | Hidrocloruro de efedrina | 1件: Ephedrine Ephedrine | 1件: D00124
D00124
| 9件: ADRA1A ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 |
| 150 | Hidrocloruro de fingolimod | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 14 |
| 151 | HIDROFEROL | - | - | - | - | 1件: 113 113 |
| 152 | Hidroferol® | - | - | - | - | 1件: 113 113 |
| 153 | HIDS DONOR | - | - | - | - | 1件: 19 19 |
| 154 | High cheese intake. | - | - | - | - | 1件: 238 238 |
| 155 | High Dietary Sodium | - | - | - | - | 1件: 49 49 |
| 156 | High dose | - | - | - | - | 1件: 97 97 |
| 157 | High dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 6 6 |
| 158 | High dose ANAVEX2-73 | - | - | - | - | 1件: 6 6 |
| 159 | High Dose Aspirin (1300 mg/day) | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1,
PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
| 160 | High dose BIBF 1120 twice daily | - | - | - | - | 1件: 85 85 |
| 161 | High Dose Budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
| 162 | High dose budesonide suspension | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
| 163 | High dose budesonide tablet | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
| 164 | High dose Dexamethasone pulses | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
| 165 | High dose lactulose | 1件: Lactulose Lactulose | 1件: D00352
D00352
| - | - | 1件: 291 291 |
| 166 | High dose levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
| 167 | High Dose LX2006 | - | - | - | - | 1件: 18 18 |
| 168 | High Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | 1件: 49 49 |
| 169 | High Dose MT-1303 | - | - | - | - | 1件: 97 97 |
| 170 | High Dose MYOBLOC | 1件: Botulinum toxin type B Botulinum toxin type B | 1件: D02735
D02735
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 |
| 171 | High dose of BIIL 284 BS tablets | - | - | - | - | 1件: 46 46 |
| 172 | High dose of budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 |
| 173 | High dose ORTD-1 | - | - | - | - | 1件: 46 46 |
| 174 | High dose TSO | - | - | - | - | 1件: 96 96 |
| 175 | High dose vehicle control | - | - | - | - | 1件: 46 46 |
| 176 | High Dose-VIS649 | - | - | - | - | 1件: 66 66 |
| 177 | High doses of Thiamine y Biotin | 2件: Biotin Biotin,
Thiamine | 2件: D00029
D00029
,
D08580
| - | - | 1件: 8 8 |
| 178 | High Fiber supplement | - | - | - | - | 1件: 6 6 |
| 179 | High milk intake. | - | - | - | - | 1件: 238 238 |
| 180 | High Oligosaccharide Group | - | - | - | - | 1件: 96 96 |
| 181 | High Phenolic Extra Virgin Olive Oil | 2件: Olea europaea leaf Olea europaea leaf,
Olive oil | 1件: D03311
D03311
| - | - | 1件: 13 13 |
| 182 | High protein high fiber diet | - | - | - | - | 2件: 93 93, 95 |
| 183 | High Protein. T-Diet plus Range | - | - | - | - | 1件: 6 6 |
| 184 | High serine diet | 1件: Serine Serine | 1件: D00016
D00016
| - | - | 1件: 96 96 |
| 185 | High water intake | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 67 67 |
| 186 | High-caloric fatty diet | - | - | - | - | 1件: 2 2 |
| 187 | High-carbohdyrate breakfast | - | - | - | - | 1件: 265 265 |
| 188 | High-dose Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 1件: 96 96 |
| 189 | High-dose intravenous immunoglobulin (IVIG) | - | - | - | - | 1件: 18 18 |
| 190 | High-dose intravenous immunoglobulin (Venoglobulin-IH) | - | - | - | - | 1件: 51 51 |
| 191 | High-dose REGN4461 | - | - | - | - | 1件: 265 265 |
| 192 | High-dose vitamin D (2000 IU per day) | 1件: Vitamin D Vitamin D | - | - | - | 1件: 274 274 |
| 193 | High-Dose Vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
| 194 | High/Low Sodium Diet | - | - | - | - | 1件: 13 13 |
| 195 | Hiomega-3 supplement of Naturalis® company - | - | - | - | - | 1件: 49 49 |
| 196 | Histidine | 1件: Histidine Histidine | 1件: D00032
D00032
| - | - | 3件: 13 13, 169, 170 |
| 197 | Histone Deacetylase Inhibitor | - | - | - | - | 1件: 127 127 |
| 198 | Histrelin | 1件: Histrelin Histrelin | 1件: D02369
D02369
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
| 199 | Histrelin Subcutaneous Implant | 1件: Histrelin Histrelin | 1件: D02369
D02369
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
| 200 | HIV Anti-retroviral Background Therapy | - | - | - | - | 1件: 265 265 |
| 201 | Hizentra | - | - | - | - | 4件: 14 14, 50, 51, 65 |
| 202 | HIZENTRA ® | - | - | - | - | 1件: 11 11 |
| 203 | Hizentra® | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 2件: 14 14, 65 |
| 204 | HK-001 | - | - | - | - | 1件: 2 2 |
| 205 | HL-085 | - | - | - | - | 1件: 34 34 |
| 206 | HL237 | - | - | - | - | 1件: 46 46 |
| 207 | HL237 tablet | - | - | - | - | 1件: 46 46 |
| 208 | HLA-B*5801 test | - | - | - | - | 1件: 38 38 |
| 209 | HLA-identical allogeneic mesoangioblasts | - | - | - | - | 1件: 113 113 |
| 210 | HLADQA1*05A>G screening | - | - | - | - | 2件: 96 96, 97 |
| 211 | HLB-001 | - | - | - | - | 1件: 246 246 |
| 212 | HLL2 | - | - | - | - | 1件: 49 49 |
| 213 | HLL2 (Epratuzumab) | 1件: Epratuzumab Epratuzumab | 1件: D04036
D04036
| 1件: CD22 CD22 💬 | 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 |
| 214 | HLL2 (trivial name or chemical description) | - | - | - | - | 1件: 49 49 |
| 215 | HLL2,IMMU-103 | - | - | - | - | 1件: 49 49 |
| 216 | HLX01 | - | - | - | - | 1件: 46 46 |
| 217 | HM10560A | - | - | - | - | 1件: 78 78 |
| 218 | HM201 | - | - | - | - | 2件: 96 96, 97 |
| 219 | HM71224 food effect | - | - | - | - | 1件: 46 46 |
| 220 | HM71224 Multiple ascending dose | - | - | - | - | 1件: 46 46 |
| 221 | HM71224 single ascending dose | - | - | - | - | 1件: 46 46 |
| 222 | HMABs | - | - | - | - | 1件: 113 113 |
| 223 | HMED-IdeS | 1件: Imlifidase Imlifidase | 1件: D11470
D11470
| - | - | 2件: 64 64, 221 |
| 224 | HMG-Coenzyme inhibitor (statin) | - | - | - | - | 1件: 218 218 |
| 225 | HMI-102 | - | - | - | - | 1件: 240 240 |
| 226 | HMI-103 | - | - | - | - | 1件: 240 240 |
| 227 | HMPL-004 | - | - | - | - | 2件: 96 96, 97 |
| 228 | HMPL-004 1800 mg/day | - | - | - | - | 1件: 97 97 |
| 229 | HMPL-004 2400 mg/day | - | - | - | - | 1件: 97 97 |
| 230 | HMPL-004 high dose | - | - | - | - | 1件: 97 97 |
| 231 | HMPL-004 low dose | - | - | - | - | 1件: 97 97 |
| 232 | HMPL-523 | - | - | - | - | 2件: 46 46, 63 |
| 233 | HMPL-523(300mg PO QD) | - | - | - | - | 1件: 61 61 |
| 234 | HMPL004-6599 | - | - | - | - | 2件: 96 96, 97 |
| 235 | HMR 1726D | - | - | - | - | 1件: 13 13 |
| 236 | HMR1726 | - | - | - | - | 1件: 13 13 |
| 237 | HMR1726D | - | - | - | - | 1件: 13 13 |
| 238 | HMSCs | - | - | - | - | 1件: 299 299 |
| 239 | HNC364 | - | - | - | - | 1件: 6 6 |
| 240 | Hologene 5 | - | - | - | - | 1件: 36 36 |
| 241 | Hologene 5 DS | - | - | - | - | 1件: 36 36 |
| 242 | HOLOGENE17 | - | - | - | - | 1件: 36 36 |
| 243 | HOLOGENE7 | - | - | - | - | 1件: 36 36 |
| 244 | Homeostasis Model Assessment of insulin resistance (HOMA) | - | - | - | - | 1件: 17 17 |
| 245 | Homologous booster | - | - | - | - | 1件: 13 13 |
| 246 | HOMSC300 | - | - | - | - | 1件: 17 17 |
| 247 | Honey | 1件: Honey Honey | 1件: D06776
D06776
| - | - | 1件: 57 57 |
| 248 | Hookworm larvae | - | - | - | - | 1件: 13 13 |
| 249 | HORA-PDE6B (AAV2/5.hPDE6B) | - | - | - | - | 1件: 90 90 |
| 250 | Hormonal balance measurements | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 81 81 |
| 251 | Hormonal profile | - | - | - | - | 1件: 113 113 |
| 252 | Hormone (prednisone) | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 |
| 253 | Horse anti-thymocyte globulin | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
| 254 | Horse anti-thymocyte globulin (ATG) | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
| 255 | Horse anti-thymocyte globulin (hATG) | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
| 256 | Horse chestnut | 1件: Horse chestnut Horse chestnut | 1件: D12028
D12028
| - | - | 1件: 210 210 |
| 257 | Horse-Anti-thymocyte-Globulin | - | - | - | - | 1件: 60 60 |
| 258 | Hourly dosing of the nychtemeral secretion of melatonin | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A,
MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 202 202 |
| 259 | HOV-12020 (Palm tocotrienols complex) | - | - | - | - | 1件: 124 124 |
| 260 | HP 129Xe | - | - | - | - | 1件: 299 299 |
| 261 | Hp 129Xenon | - | - | - | - | 1件: 228 228 |
| 262 | HP 3He | - | - | - | - | 1件: 299 299 |
| 263 | HP-3000 (ropinirole hydrochloride patch) | 1件: Ropinirole Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2,
DRD3,
DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
| 264 | HP-3000 placebo | - | - | - | - | 1件: 6 6 |
| 265 | HP-3000(ropinirole hydrochloride patch) | 1件: Ropinirole Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2,
DRD3,
DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
| 266 | HP184 | - | - | - | - | 1件: 13 13 |
| 267 | HP802-247 | - | - | - | - | 1件: 36 36 |
| 268 | HPC cell infusion | - | - | - | - | 1件: 45 45 |
| 269 | HPN-100 | - | - | - | - | 1件: 251 251 |
| 270 | HPV prophylactic vaccine Gardasil | 1件: Human papillomavirus type 6 L1 capsid protein antigen Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 |
| 271 | HR19042 capsule | - | - | - | - | 1件: 66 66 |
| 272 | HR19042 Capsules | - | - | - | - | 1件: 66 66 |
| 273 | HRA052015 | - | - | - | - | 1件: 75 75 |
| 274 | HRA052015 (mifepristone) | 1件: Mifepristone Mifepristone | 1件: D00585
D00585
| 2件: NR3C1 NR3C1,
PGR 💬 | 6件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 75 75 |
| 275 | HrIL-2 active | - | - | - | - | 3件: 46 46, 49, 53 |
| 276 | HRPC | - | - | - | - | 1件: 90 90 |
| 277 | HRPC DP | - | - | - | - | 1件: 90 90 |
| 278 | HSK31858 | - | - | - | - | 1件: 299 299 |
| 279 | HST5040 | - | - | - | - | 2件: 245 245, 246 |
| 280 | HT-100 | - | - | - | - | 1件: 113 113 |
| 281 | HTD1801 | - | - | - | - | 1件: 94 94 |
| 282 | HTEA | - | - | - | - | 1件: 57 57 |
| 283 | HTK cardioplegia | - | - | - | - | 1件: 215 215 |
| 284 | HTLP | - | - | - | - | 1件: 65 65 |
| 285 | Hu Leptin (A-100) | 1件: Leptin Leptin | - | - | - | 1件: 265 265 |
| 286 | Hu MiK-Beta-1 | - | - | - | - | 1件: 26 26 |
| 287 | Huaiqihuang Granule | - | - | - | - | 2件: 63 63, 222 |
| 288 | Huaiqinhuang | - | - | - | - | 1件: 224 224 |
| 289 | Huang qi gui zhi wu wu granule | - | - | - | - | 1件: 46 46 |
| 290 | HUC-MSC + DMARDs | - | - | - | - | 1件: 46 46 |
| 291 | HuCNS-SC | - | - | - | - | 1件: 19 19 |
| 292 | HuCNS-SC cells | - | - | - | - | 1件: 139 139 |
| 293 | HuCNS-SC transplant in the lead-in phase | - | - | - | - | 1件: 139 139 |
| 294 | HuL001 | - | - | - | - | 1件: 85 85 |
| 295 | Hulio | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
| 296 | HuM291 | - | - | - | - | 2件: 96 96, 97 |
| 297 | HuM291) | - | - | - | - | 1件: 97 97 |
| 298 | Humalog Mix50 100 U/ml sospensione iniettabile | - | - | - | - | 1件: 78 78 |
| 299 | Human acylated ghrelin | 1件: Lenomorelin Lenomorelin | - | - | - | 1件: 78 78 |
| 300 | Human albumin | 1件: Albumin human Albumin human | 1件: D02792
D02792
| - | - | 2件: 2 2, 96 |
| 301 | HUMAN ALBUMIN AS MACROAGGREGATES | 1件: Albumin human Albumin human | 1件: D02792
D02792
| - | - | 1件: 96 96 |
| 302 | HUMAN ALBUMIN SOLUTION | 1件: Albumin human Albumin human | 1件: D02792
D02792
| - | - | 1件: 2 2 |
| 303 | Human allogeneic adipose tissue-derived mesenchymal stem cells expanded | - | - | - | - | 1件: 36 36 |
| 304 | Human Allogeneic WJ-MSCs | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 |
| 305 | Human anti TNF-alpha monoclonal | - | - | - | - | 1件: 46 46 |
| 306 | Human anti TNF-alpha monoclonal antibody | - | - | - | - | 2件: 46 46, 84 |
| 307 | Human anti-IL 12/23 monoclonal antibody | - | - | - | - | 1件: 84 84 |
| 308 | Human Anti-IL-12 Antibody | - | - | - | - | 1件: 96 96 |
| 309 | Human anti-IL-12 IgG1 Mab | - | - | - | - | 1件: 13 13 |
| 310 | Human anti-IL-12 Mab | - | - | - | - | 1件: 13 13 |
| 311 | Human anti-IL6 monoclonal antibody | - | - | - | - | 1件: 46 46 |
| 312 | Human anti-IP10 monoclonal antibody | - | - | - | - | 2件: 96 96, 97 |
| 313 | Human anti-LINGO-1 monoclonal antibody | - | - | - | - | 1件: 13 13 |
| 314 | HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY | - | - | - | - | 1件: 3 3 |
| 315 | Human Anti-TNF IgG1 Monoclonal Antibody | - | - | - | - | 3件: 46 46, 97, 271 |
| 316 | Human anti-TNF-alpha monoclonal antibody | - | - | - | - | 3件: 46 46, 97, 107 |
| 317 | Human anti-TNFa monoclonal antibody | - | - | - | - | 1件: 271 271 |
| 318 | Human Anti-TNFalfa | - | - | - | - | 3件: 46 46, 97, 271 |
| 319 | Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody | - | - | - | - | 1件: 51 51 |
| 320 | Human autologous mesenchymal stem cells | - | - | - | - | 2件: 2 2, 13 |
| 321 | HUMAN COAGULATION FACTOR VIII | 2件: Antihemophilic factor human Antihemophilic factor human,
Beroctocog alfa | - | - | - | 1件: 288 288 |
| 322 | Human coagulation Factor VIII / von Willebrand Factor | 2件: Antihemophilic factor human Antihemophilic factor human,
Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 323 | Human coagulation factor VIII associated with Von Willebrand factor (VWF) | 2件: Antihemophilic factor human Antihemophilic factor human,
Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 324 | Human Coagulation Factor VIII, Von Willebrand Factor | 2件: Antihemophilic factor human Antihemophilic factor human,
Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 325 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX | 3件: Antihemophilic factor human Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 326 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND HUMAN COAGULATION FACTOR | 2件: Antihemophilic factor human Antihemophilic factor human,
Beroctocog alfa | - | - | - | 1件: 288 288 |
| 327 | Human Coagulation FACTOR X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
| 328 | Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh | - | - | - | - | 1件: 36 36 |
| 329 | Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE) | - | - | - | - | 1件: 90 90 |
| 330 | Human factor X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
| 331 | Human fetal-derived Neural Stem Cells (hNSCs) | - | - | - | - | 1件: 13 13 |
| 332 | HUMAN FIBRINOGEN | 1件: Fibrinogen human Fibrinogen human | - | - | - | 1件: 65 65 |
| 333 | Human Fibrinogen Concentrate | 1件: Fibrinogen human Fibrinogen human | - | - | - | 1件: 65 65 |
| 334 | Human fibroblast-derived dermal substitute, Dermagraft | - | - | - | - | 1件: 36 36 |
| 335 | Human Glucocerebrosidase (prGCD) | 1件: Taliglucerase alfa Taliglucerase alfa | 1件: D09675
D09675
| 1件: GBA1 GBA1 💬 | 4件: Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 |
| 336 | Human glucocerebrosidase cDNA | - | - | - | - | 1件: 19 19 |
| 337 | Human glucocerebrosidase gene into autologous peripheral blood stem cells | - | - | - | - | 1件: 19 19 |
| 338 | Human Growth Hormone | 1件: Somatotropin Somatotropin | - | - | - | 5件: 78 78, 187, 193, 265, 276 |
| 339 | Human Growth Hormone (1-134) | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 |
| 340 | Human Heterologous Liver Cells | - | - | - | - | 1件: 251 251 |
| 341 | Human heterologous liver cells (for infusion) | - | - | - | - | 1件: 251 251 |
| 342 | Human IgG1 monoclonal antibody against alpha-synuclein | - | - | - | - | 1件: 17 17 |
| 343 | HUMAN IGG4 ISOTYPE MONOCLONAL (IL2-RG) ANTIBODY | - | - | - | - | 1件: 60 60 |
| 344 | Human IgG4 monoclonal antibody against CD40 | - | - | - | - | 1件: 46 46 |
| 345 | Human Immunglobulin G (IgG) | - | - | - | - | 1件: 65 65 |
| 346 | Human Immunoglobulin | - | - | - | - | 2件: 63 63, 65 |
| 347 | HUMAN IMMUNOGLOBULIN G | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 4件: 14 14, 50, 63, 65 |
| 348 | Human insulin | 1件: Insulin human Insulin human | 1件: D03230
D03230
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 2件: 96 96, 156 |
| 349 | Human interferon beta | 1件: Human interferon beta Human interferon beta | - | - | - | 2件: 13 13, 26 |
| 350 | Human interferon beta 1a (Rebif) | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
| 351 | Human interferon beta-1a and glatiramer acetate | 4件: Acetate Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
| 352 | Human interleukin-2 | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 1件: 35 35 |
| 353 | HUMAN LEUCOCYTE INTERFERON-ALPHA | - | - | - | - | 1件: 13 13 |
| 354 | Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40 | - | - | - | - | 1件: 96 96 |
| 355 | Human monoclonal antibody (CNTO 1275) to interleukin-12p40 | - | - | - | - | 1件: 13 13 |
| 356 | Human monoclonal antibody directed against CD20 on B-cells | - | - | - | - | 1件: 46 46 |
| 357 | Human monoclonal antibody directed against complement 5 protein | - | - | - | - | 1件: 62 62 |
| 358 | Human neural stem cell | - | - | - | - | 1件: 6 6 |
| 359 | Human Neural Stem Cells | - | - | - | - | 2件: 2 2, 13 |
| 360 | Human normal 10% immunoglobulin for intravenous administration | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 14 14 |
| 361 | Human normal 10% immunoglobulin for intravenous administrationn | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 14 14 |
| 362 | Human normal immunoglobulin | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 9件: 11 11, 13, 14, 43, 45, 50, 51, 63, 65 |
| 363 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 4件: 11 11, 14, 63, 65 |
| 364 | Human normal immunoglobulin (IVIg) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 3件: 14 14, 50, 65 |
| 365 | Human normal immunoglobulin (SCIg) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 14 14 |
| 366 | Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
| 367 | Human normal immunoglobulin (subcutaneous) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
| 368 | HUMAN NORMAL IMMUNOGLOBULIN FOR | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
| 369 | Human normal immunoglobulin for intravenous (IV) administration | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 51 51 |
| 370 | Human normal immunoglobulin for intravenous administration | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 3件: 14 14, 51, 65 |
| 371 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 2件: 63 63, 65 |
| 372 | Human normal immunoglobulin for intravenous use (IVIG) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
| 373 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 63 63 |
| 374 | Human normal immunoglobulin for subcutaneous administration | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 2件: 51 51, 65 |
| 375 | Human Normal Immunoglobulin for Subcutaneous Administration (IGSC) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
| 376 | Human normal immunoglobulin G (IgG > 98% purity) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 3件: 14 14, 63, 65 |
| 377 | Human normal immunoglobulin G (IgG) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 11 11 |
| 378 | Human normal immunoglogulin (IVIg) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 50 50 |
| 379 | Human papillomavirus vaccination (Gardasil) | 1件: Human papillomavirus type 6 L1 capsid protein antigen Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 |
| 380 | Human Placenta-Derived Cells PDA001 Intravenous Infusion | - | - | - | - | 1件: 96 96 |
| 381 | Human Placental Derived Stem Cell | - | - | - | - | 4件: 19 19, 20, 60, 284 |
| 382 | HUMAN PLASMA FOR FRACTIONATION | - | - | - | - | 1件: 96 96 |
| 383 | Human primary Retinal Pigment Epithelial (HuRPE) cells | - | - | - | - | 1件: 90 90 |
| 384 | Human recombinant growth hormone | 1件: Somatotropin Somatotropin | - | - | - | 2件: 13 13, 299 |
| 385 | Human Recombinant IgG1, lambda | - | - | - | - | 1件: 46 46 |
| 386 | Human recombinant leptin (metreleptin) | 2件: Leptin Leptin,
Metreleptin | 1件: D05014
D05014
| 1件: LEPR LEPR 💬 | 6件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬 | 1件: 265 265 |
| 387 | Human recombinant parathyroid Hormone | 1件: Parathyroid hormone Parathyroid hormone | 1件: D05364
D05364
| 2件: PTH1R PTH1R,
PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 |
| 388 | Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 172 172 |
| 389 | Human retinal progenitor cells | - | - | - | - | 1件: 90 90 |
| 390 | Human Retinal Progenitor Cells Drug Product | - | - | - | - | 1件: 90 90 |
| 391 | Human Secretin | 1件: Secretin human Secretin human | - | - | - | 1件: 298 298 |
| 392 | Human serum albumin | 1件: Albumin human Albumin human | 1件: D02792
D02792
| - | - | 1件: 78 78 |
| 393 | HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH) | 2件: Albumin human Albumin human,
Somatotropin | 1件: D02792
D02792
| - | - | 1件: 78 78 |
| 394 | Human Serum Albumin (HSA) fused to somatropin | 2件: Albumin human Albumin human,
Somatotropin | 1件: D02792
D02792
| - | - | 1件: 78 78 |
| 395 | Human soluble recombinant Fc-gamma receptor IIB | - | - | - | - | 1件: 66 66 |
| 396 | Human Stem Cells | - | - | - | - | 1件: 6 6 |
| 397 | Human T Lymphoid Progenitor (HTLP) injection | - | - | - | - | 1件: 65 65 |
| 398 | Human TH-SC01 cell injection | - | - | - | - | 1件: 96 96 |
| 399 | Human Transthyretin Antisense Oligonucleotide | - | - | - | - | 1件: 28 28 |
| 400 | Human Umbilical Cord Blood-derived Mesenchymal Stem Cells | - | - | - | - | 1件: 36 36 |
| 401 | Human umbilical cord derived MSC transplantation for SLE | - | - | - | - | 1件: 49 49 |
| 402 | Human umbilical cord mesenchymal stem cell injection | - | - | - | - | 1件: 85 85 |
| 403 | Human Umbilical Cord Mesenchymal Stem Cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 3件: 13 13, 96, 113 |
| 404 | Human umbilical cord mesenchymal stem cells (UC-MSCs) | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 96 96 |
| 405 | Human umbilical cord-derived MSCs | - | - | - | - | 1件: 271 271 |
| 406 | HUMAN VON WILLEBRAND FACTOR | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 407 | Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII) | 2件: Beroctocog alfa Beroctocog alfa,
Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 408 | Human VWF/FVIII concentrate | - | - | - | - | 1件: 288 288 |
| 409 | Human whole exome | - | - | - | - | 1件: 285 285 |
| 410 | Humanised anti-CD 20 antibody | - | - | - | - | 1件: 46 46 |
| 411 | Humanised anti-CD4 IgG1 monoclonal | - | - | - | - | 1件: 46 46 |
| 412 | Humanised IgG1 monoclonal antibody against blood dendritic cell antigen 2 | - | - | - | - | 1件: 49 49 |
| 413 | Humanised IgG1 monoclonal antibody against human eotaxin-2 | - | - | - | - | 1件: 94 94 |
| 414 | Humanised IgG1K monoclonal antibody against interferon beta | 1件: Human interferon beta Human interferon beta | - | - | - | 1件: 50 50 |
| 415 | Humanized anti-alpha v beta 6 mAb | - | - | - | - | 1件: 85 85 |
| 416 | Humanized IgG1 kappa antiamyloid | - | - | - | - | 1件: 28 28 |
| 417 | Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody | - | - | - | - | 1件: 28 28 |
| 418 | Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody | - | - | - | - | 1件: 46 46 |
| 419 | Humanized recombinant IgG4 monoclonal antibody against CD-127 | - | - | - | - | 1件: 97 97 |
| 420 | Humanized TNFa monoclonal antibody | - | - | - | - | 1件: 46 46 |
| 421 | Humate-P | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 422 | Humatrope | - | - | - | - | 2件: 78 78, 274 |
| 423 | Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 |
| 424 | Humatrope® 6 mg, powder and solvent for solution for injection | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 |
| 425 | HuMax-CD20 | 1件: Ofatumumab Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 46 |
| 426 | HUMAX-CD38 | - | - | - | - | 2件: 28 28, 63 |
| 427 | HuMax-CD38, 3003-005 | - | - | - | - | 1件: 28 28 |
| 428 | HuMax-CD4 | 1件: Zanolimumab Zanolimumab | 1件: D06356
D06356
| 1件: CD4 CD4 💬 | 14件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 1件: 46 46 |
| 429 | HUMIRA | - | - | - | - | 9件: 46 46, 56, 84, 96, 97, 107, 160, 269, 271 |
| 430 | Humira (adalimumab original) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
| 431 | HUMIRA (ADALIMUMAB) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 |
| 432 | Humira (adalimumab) 40 mg in 0.4 ml s.c. injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 433 | Humira (adalimumab) 40 mg s.c. injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 434 | Humira (adalimumab) 40mg in 0.4 ml s.c. injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 435 | Humira (adalimumab) 40mg in 0.4ml s.c.injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 436 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER | - | - | - | - | 2件: 56 56, 97 |
| 437 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 2 SIRINGHE PRERIEMPITE 0.8 ML + 2 TAMPONI IMBEVUTI DI ALCOL IN 1 BLISTER | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 438 | HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL | - | - | - | - | 2件: 46 46, 96 |
| 439 | Humira 20 mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
| 440 | Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
| 441 | Humira 40 mg injekcní roztok v predplnené injekcní stríkacce | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
| 442 | Humira 40 mg injeksjonsvæske, oppløsning, i ferdigfylt sprøyte | - | - | - | - | 1件: 46 46 |
| 443 | HUMIRA 40 mg solución inyectable en jeringa precargada | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 |
| 444 | Humira 40 mg solution for injection in pre-filled pen | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
| 445 | Humira 40 mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 |
| 446 | Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
| 447 | Humira 40 mg solution for injection in pre-filled syringes | - | - | - | - | 1件: 97 97 |
| 448 | Humira 40 mg/0.8 ml solution for injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 |
| 449 | Humira 40 mg/0.8 ml solution for injection for paediatric use | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
| 450 | Humira 40mg Injektionslösung | - | - | - | - | 1件: 46 46 |
| 451 | HUMIRA 40Mg Solution for Injection | - | - | - | - | 2件: 96 96, 97 |
| 452 | Humira 40mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 453 | Humira 40mg solution for injection in pre-filled syringe (adalimumab) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 454 | Humira 40mg/0.4ml pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
| 455 | Humira 40mg/0.8 ml solution for injection for paediatric use | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 456 | Humira 40mg/0.8ml solution for injection for paediatric use | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
| 457 | Humira 40mg/0.8ml solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 458 | Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
| 459 | Humira pre-filled PEN | - | - | - | - | 1件: 96 96 |
| 460 | Humira SC | - | - | - | - | 1件: 46 46 |
| 461 | HUMIRA ® | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
| 462 | Humira ® (Adalimumab) 40mg/0.8mL Pre-filled Syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 463 | HUMIRA*SC 2SIR+F 40MG 0,8ML+2T | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 |
| 464 | Humira, 40 mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 465 | Humira, Hulio, Amgevita, Hyrimoz, Idacio, Imraldi | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 466 | Humira® | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 |
| 467 | Humira® (adalimumab) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 468 | Humira® 40 mg Injektionslösung in Fertigspritze | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 469 | Humira® 40 mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 470 | Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 471 | Hunterase | 1件: Idursulfase beta Idursulfase beta | 1件: D11025
D11025
| 1件: IDS IDS 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 |
| 472 | Huolingshengji Granules | - | - | - | - | 1件: 2 2 |
| 473 | Hyaluronate | 1件: Hyaluronic acid Hyaluronic acid | 1件: D08043
D08043
| - | - | 2件: 53 53, 97 |
| 474 | Hyaluronic acid | 1件: Hyaluronic acid Hyaluronic acid | 1件: D08043
D08043
| - | - | 5件: 46 46, 53, 70, 226, 231 |
| 475 | Hyaluronic Acid and Chondroitin Sulfate | 3件: Chondroitin sulfate Chondroitin sulfate,
Hyaluronic acid,
Sulfate ion | 1件: D08043
D08043
| - | - | 1件: 226 226 |
| 476 | Hyaluronic Acid Inhalation Solution | 1件: Hyaluronic acid Hyaluronic acid | 1件: D08043
D08043
| - | - | 1件: 231 231 |
| 477 | Hyaluronic acid/chondroitin sulfate | 3件: Chondroitin sulfate Chondroitin sulfate,
Hyaluronic acid,
Sulfate ion | 1件: D08043
D08043
| - | - | 1件: 226 226 |
| 478 | Hyaluronidase | 1件: Hyaluronidase Hyaluronidase | 3件: D04455
D04455
,
D04456
,
D06604
| - | - | 5件: 14 14, 28, 51, 65, 331 |
| 479 | Hyaluronidase injected intradermally | 1件: Hyaluronidase Hyaluronidase | 3件: D04455
D04455
,
D04456
,
D06604
| - | - | 1件: 51 51 |
| 480 | Hyaluronoglucosaminidase | 1件: Hyaluronidase Hyaluronidase | 3件: D04455
D04455
,
D04456
,
D06604
| - | - | 1件: 65 65 |
| 481 | Hydralazine | 1件: Hydralazine Hydralazine | 1件: D08044
D08044
| 1件: AOC3 AOC3 💬 | 5件: Glycine, serine and threonine metabolism Glycine, serine and threonine metabolism, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, beta-Alanine metabolism 💬 | 1件: 67 67 |
| 482 | Hydrochloorthiazide | - | - | - | - | 1件: 225 225 |
| 483 | HYDROCHLOROTHIAZIDE | 1件: Hydrochlorothiazide Hydrochlorothiazide | 1件: D00340
D00340
| 1件: SLC12A3 SLC12A3 💬 | - | 4件: 13 13, 67, 225, 235 |
| 484 | Hydrochlorothiazide 25 mg | 1件: Hydrochlorothiazide Hydrochlorothiazide | 1件: D00340
D00340
| 1件: SLC12A3 SLC12A3 💬 | - | 1件: 67 67 |
| 485 | Hydrochlorothiazide/amiloride | 2件: Amiloride Amiloride,
Hydrochlorothiazide | 2件: D00340
D00340
,
D07447
| 4件: SCNN1A SCNN1A,
SCNN1B,
SCNN1G,
SLC12A3 💬 | - | 1件: 225 225 |
| 486 | Hydrocortison 100 mg (Pfizer®) in 2 ml solvent | - | - | - | - | 1件: 83 83 |
| 487 | Hydrocortisone | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 |
| 488 | Hydrocortisone (Solucortef) | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
| 489 | Hydrocortisone 100mg/ml | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 |
| 490 | Hydrocortisone 10mg | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
| 491 | Hydrocortisone 10mg Tablet | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
| 492 | Hydrocortisone 10mg Tablets | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
| 493 | Hydrocortisone 20mg Tablets | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
| 494 | HYDROCORTISONE ACETATE | 2件: Acetate Acetate,
Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
| 495 | Hydrocortisone cream | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
| 496 | Hydrocortisone cream 1% | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
| 497 | Hydrocortisone cream 10mg/g FNA Fagron | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
| 498 | HYDROCORTISONE HYDROGEN SUCCINATE | 3件: Hydrocortisone Hydrocortisone,
Hydrocortisone succinate,
Hydrogen | 2件: D00088
D00088
,
D01442
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 |
| 499 | HYDROCORTISONE MICRONIZED | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
| 500 | Hydrocortisone Modified Release Capsules | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
| 501 | HYDROCORTISONE ROUSSEL | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 |
| 502 | Hydrocortisone sodium acetate | 3件: Acetate Acetate,
Hydrocortisone,
Sodium acetate | 2件: D00088
D00088
,
D01779
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
| 503 | HYDROCORTISONE SODIUM PHOSPHATE | 2件: Hydrocortisone Hydrocortisone,
Phosphate ion | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 53 53, 81, 83 |
| 504 | HYDROCORTISONE SODIUM SUCCINATE | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 81 81, 83, 97 |
| 505 | Hydrocortisone tablet 2.5 mg | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
| 506 | Hydrocortisone TAKEDA, tabletter | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 |
| 507 | HYDROCORTISONE- hydrocortisone tablet | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
| 508 | Hydrocortisonum | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 |
| 509 | Hydrocortone | - | - | - | - | 1件: 78 78 |
| 510 | Hydrogen | 1件: Hydrogen Hydrogen | - | - | - | 6件: 5 5, 6, 17, 83, 97, 226 |
| 511 | Hydrokortison | - | - | - | - | 1件: 41 41 |
| 512 | Hydrokortison APL kapsel 2,5 mg | - | - | - | - | 1件: 83 83 |
| 513 | Hydrokortison Glostrup 5 mg | - | - | - | - | 1件: 78 78 |
| 514 | Hydrokortison orion | - | - | - | - | 1件: 41 41 |
| 515 | Hydrolyzed guar gum | 1件: Guar gum Guar gum | 1件: D04403
D04403
| - | - | 1件: 6 6 |
| 516 | Hydromorphone | 1件: Hydromorphone Hydromorphone | 1件: D08047
D08047
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 |
| 517 | Hydroxide | 1件: Hydroxide ion Hydroxide ion | - | - | - | 5件: 11 11, 46, 96, 97, 284 |
| 518 | Hydroxocobalamin | 1件: Hydroxocobalamin Hydroxocobalamin | 1件: D01027
D01027
| - | - | 1件: 97 97 |
| 519 | Hydroxocobalamin with Butyrate | 2件: Butyric Acid Butyric Acid,
Hydroxocobalamin | 1件: D01027
D01027
| - | - | 1件: 97 97 |
| 520 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 27件: 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
| 521 | Hydroxychloroquine (Z0188) | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 49 49 |
| 522 | Hydroxychloroquine + low-dose prednisone | 2件: Hydroxychloroquine Hydroxychloroquine,
Prednisone | 2件: D00473
D00473
,
D08050
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
| 523 | Hydroxychloroquine + Prednisone | 2件: Hydroxychloroquine Hydroxychloroquine,
Prednisone | 2件: D00473
D00473
,
D08050
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
| 524 | Hydroxychloroquine 400mg/d | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 53 53 |
| 525 | Hydroxychloroquine higher dose | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 90 90 |
| 526 | Hydroxychloroquine lower dose | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 90 90 |
| 527 | Hydroxychloroquine or Chloroquine | 2件: Chloroquine Chloroquine,
Hydroxychloroquine | 2件: D02366
D02366
,
D08050
| - | - | 1件: 49 49 |
| 528 | Hydroxychloroquine Pill | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 13 13 |
| 529 | Hydroxychloroquine reduced | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 49 49 |
| 530 | Hydroxychloroquine sulfate | 2件: Hydroxychloroquine Hydroxychloroquine,
Sulfate ion | 1件: D08050
D08050
| - | - | 4件: 13 13, 46, 53, 66 |
| 531 | Hydroxychloroquine Sulfate 100 milligram (mg) Tab | 2件: Hydroxychloroquine Hydroxychloroquine,
Sulfate ion | 1件: D08050
D08050
| - | - | 1件: 218 218 |
| 532 | HYDROXYCHLOROQUINE SULPHATE | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 96 96 |
| 533 | Hydroxycholoquine | - | - | - | - | 1件: 46 46 |
| 534 | Hydroxycloroquina | - | - | - | - | 1件: 46 46 |
| 535 | Hydroxypropyl-beta-cyclodextrin | 1件: Betadex Betadex | 1件: D02401
D02401
| - | - | 1件: 19 19 |
| 536 | Hydroxypropyl-ß-cyclodextrin | - | - | - | - | 1件: 19 19 |
| 537 | Hydroxyurea | 1件: Hydroxyurea Hydroxyurea | 1件: D00341
D00341
| 1件: RRM2 RRM2 💬 | 7件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | 8件: 3 3, 13, 19, 20, 65, 85, 86, 284 |
| 538 | Hylase | - | - | - | - | 1件: 46 46 |
| 539 | Hymecromone | 1件: Hymecromone Hymecromone | 1件: D00170
D00170
| - | - | 1件: 94 94 |
| 540 | HYNR-CS inj | - | - | - | - | 1件: 2 2 |
| 541 | HYNR-CS-Allo | - | - | - | - | 1件: 2 2 |
| 542 | HYNRCS-Allo inj | - | - | - | - | 1件: 2 2 |
| 543 | Hyperglycemic clamp | - | - | - | - | 1件: 299 299 |
| 544 | Hyperglycemic Clamp with concurrent GIP infusion | - | - | - | - | 1件: 299 299 |
| 545 | Hyperglycemic clamp with concurrent GLP-1 infusion | - | - | - | - | 1件: 299 299 |
| 546 | Hyperimmune caprine serum | - | - | - | - | 1件: 51 51 |
| 547 | Hyperimmune caprine serum against HIV lysate | - | - | - | - | 1件: 13 13 |
| 548 | Hyperinsulinemic euglycemic clamp | - | - | - | - | 2件: 316 316, 317 |
| 549 | HYPERIUM | 1件: Rilmenidine Rilmenidine | 1件: D08482
D08482
| 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 8 8 |
| 550 | Hyperoxia | - | - | - | - | 2件: 51 51, 85 |
| 551 | Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 85 85 |
| 552 | Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 85 85 |
| 553 | Hyperpolarized 129-Xenon gas | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 85 85 |
| 554 | Hyperpolarized 129Xe | - | - | - | - | 1件: 86 86 |
| 555 | Hyperpolarized 13C-Pyruvate | - | - | - | - | 1件: 58 58 |
| 556 | Hyperpolarized [1-13C]pyruvate | - | - | - | - | 2件: 2 2, 67 |
| 557 | Hyperpolarized Helium-3 | 2件: Helium Helium,
Helium He-3 | 1件: D04420
D04420
| - | - | 1件: 299 299 |
| 558 | Hyperpolarized Helium-3 MRI | 2件: Helium Helium,
Helium He-3 | 1件: D04420
D04420
| - | - | 1件: 228 228 |
| 559 | Hyperpolarized Helium-3 MRI of the chest | 2件: Helium Helium,
Helium He-3 | 1件: D04420
D04420
| - | - | 1件: 299 299 |
| 560 | Hyperpolarized Xe129 | - | - | - | - | 4件: 51 51, 85, 86, 299 |
| 561 | Hyperpolarized Xenon | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
| 562 | Hyperpolarized Xenon 129 | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
| 563 | Hyperpolarized Xenon gas | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
| 564 | Hyperpolarized xenon-129 | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
| 565 | Hypersaline | - | - | - | - | 1件: 294 294 |
| 566 | Hypertonic bicarbonate | - | - | - | - | 1件: 299 299 |
| 567 | HYPERTONIC SALINE | - | - | - | - | 1件: 299 299 |
| 568 | Hypertonic saline (7 %) and isotonic saline (0.9%) | - | - | - | - | 1件: 299 299 |
| 569 | Hypertonic saline (7%) | - | - | - | - | 1件: 299 299 |
| 570 | Hypertonic saline 6% - | - | - | - | - | 1件: 299 299 |
| 571 | Hypertonic Saline 7% | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
| 572 | Hypertonic saline solution | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
| 573 | Hypoestoxide | - | - | - | - | 1件: 6 6 |
| 574 | HypotonicTreprostinil Solution | - | - | - | - | 1件: 86 86 |
| 575 | Hypoxic Gas Mixture | - | - | - | - | 1件: 6 6 |
| 576 | Hypro | - | - | - | - | 1件: 75 75 |
| 577 | HyQvia | 1件: Hyaluronidase (human recombinant) Hyaluronidase (human recombinant) | - | - | - | 2件: 14 14, 65 |
| 578 | HyQvia 100 mg/ml solution for infusion for subcutaneous use | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
| 579 | Hyrimoz | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 |
| 580 | HZN-825 | - | - | - | - | 2件: 51 51, 85 |
| 581 | HZN-825 BID | - | - | - | - | 1件: 51 51 |
| 582 | HZN-825 QD | - | - | - | - | 1件: 51 51 |
| 583 | HZT-501 | 1件: HZT-501 HZT-501 | - | - | - | 1件: 46 46 |